Pan Cancer T

Pan Cancer T

Biotechnologisch onderzoek

Rotterdam, South Holland 1.234 volgers

Pan Cancer T is a biotechnology company developing T cell receptor (TCR) T-cell therapy for solid tumors.

Over ons

Pan Cancer T is a biotechnology spin-out (Erasmus MC, Rotterdam) focussed on the discovery and development of T cell receptor (TCR) T cell therapies. We exploit the 20 years of pioneering in adoptive T cell therapy as a springboard to breakthrough treatment of solid tumors. Pan Cancer T develops natural affinity TCR T cell therapies towards unique and proprietary intracellular targets expressed by multiple solid tumors, and make T cell therapy maximally accessible despite the tumor micro-environment challenges.

Branche
Biotechnologisch onderzoek
Bedrijfsgrootte
2-10 medewerkers
Hoofdkantoor
Rotterdam, South Holland
Type
Particuliere onderneming
Opgericht
2020

Locaties

Medewerkers van Pan Cancer T

Updates

Vergelijkbare pagina’s

Door vacatures bladeren

Financiering

Pan Cancer T 1 ronde in totaal

Laatste ronde

Basis

US$ 4.608.685,00

Bekijk meer informatie over Crunchbase